Chevy Chase Trust
UTHR icon

Chevy Chase Trust’s United Therapeutics UTHR Stock Holding History

Chevy Chase Trust’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.5M Sell
15,680
-142
-0.9% -$80K 0.02% 437
2026
Q1 		$9.38M Sell
15,822
-809
-5% -$403K 0.03% 409
2025
Q4 		$8.1M Sell
16,631
-488
-3% -$227K 0.02% 452
2025
Q3 		$7.18M Sell
17,119
-10,938
-39% -$3.68M 0.02% 459
2025
Q2 		$8.06M Buy
28,057
+5,393
+24% +$1.61M 0.02% 444
2025
Q1 		$6.99M Sell
22,664
-62
-0.3% -$21.2K 0.02% 462
2024
Q4 		$8.02M Sell
22,726
-323
-1% -$119K 0.02% 444
2024
Q3 		$8.26M Buy
23,049
+11,890
+107% +$4.02M 0.03% 445
2024
Q2 		$3.55M Buy
+11,159
New +$2.95M 0.01% 532
2020
Q1 		– Sell
-357
Closed -$31K – 1015
2019
Q4 		$31K Buy
+357
New +$31.4K ﹤0.01% 935
2016
Q1 		– Sell
-1,819
Closed -$285K – 670
2015
Q4 		$285K Sell
1,819
-5
-0.3% -$728 ﹤0.01% 615
2015
Q3 		$239K Hold
1,824
– – ﹤0.01% 623
2015
Q2 		$317K Hold
1,824
– – ﹤0.01% 611
2015
Q1 		$315K Sell
1,824
-58
-3% -$8.84K ﹤0.01% 618
2014
Q4 		$244K Hold
1,882
– – ﹤0.01% 644
2014
Q3 		$242K Buy
+1,882
New +$194K ﹤0.01% 658

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Chevy Chase Trust's UTHR Position: Q2 2026 in Review

Chevy Chase Trust reduced its United Therapeutics (UTHR) stake by 0.9% in Q2 2026, selling an estimated $80K and leaving 15,680 shares worth $8.5M. The position accounts for 0.02% of the portfolio, ranked #437.

Chevy Chase Trust first reported a position in UTHR in Q3 2014 and has held it in 16 quarters since. The position peaked at $9.38M in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Chevy Chase Trust held 15,680 shares of United Therapeutics worth $8.5M as of Q2 2026.
  • Chevy Chase Trust sold 142 United Therapeutics shares in Q2 2026, an estimated $80K.
  • United Therapeutics made up 0.02% of Chevy Chase Trust's portfolio in Q2 2026, its #437 holding.
  • Chevy Chase Trust first reported a position in United Therapeutics in Q3 2014 and has held it in 16 quarters since.
  • Chevy Chase Trust's United Therapeutics position peaked at $9.38M in Q1 2026.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Chevy Chase Trust's 13F filing for Q2 2026, filed 14 Aug 2026.